<?xml version="1.0" encoding="UTF-8"?>
<p>AG-S is a named co-inventor on technology patents own by Icahn School of Medicine at Mount Sinai (ISMMS) related to using live attenuated influenza virus vaccines lacking the NS1 virulence gene, exclusively licensed to Vivaldi Biosciences, Inc. AG-S is a co-founder of and holds equity in Vivaldi Biosciences, Inc., a privately-held start-up company in which ISMMS also holds equity. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
